ArticleChild psychiatry and human development2026
Feasibility, Acceptability, and Preliminary Effectiveness of a Remote Parent Training in Exposure Therapy for Youth Specific Phobia.
Article in Child psychiatry and human development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Specific phobias (SPs) in childhood are common, impairing, and treatable, yet access to gold-standard exposure therapy remains limited. Parent-led interventions delivered via telehealth may help overcome these barriers. This pilot study examined the feasibility, acceptability, and preliminary effectiveness of a co-designed, brief, group-based parent-training program in exposure therapy for SP of dogs, delivered via videoconference. Three families (children: M age = 7.33 years, SD = 0.58) completed three parent group videoconference sessions plus two boosters, and outcomes were assessed at post-treatment and at a 1-month follow up. Feasibility was excellent, with 100% retention; acceptability was supported by high satisfaction ratings and positive qualitative feedback. Clinician severity ratings of SP decreased significantly across time-points, parent-rated target symptoms declined, and all children met reliable change at post-treatment and 1-month follow-up based on their primary SP CSR. In regards to diagnostic remission (CSR < 4), rates were 33% at post-treatment, increasing to 67% at 1-month follow-up. Preliminary outcome analyses using non-parametric tests, suggested large effects for increased global functioning (CGAS), decreased parent-reported anxiety (SCAS-P) and child dysfunctional phobic beliefs, with stable child self-report anxiety (SCAS-C). Parent confidence in managing their child's SP improved, but not significantly. Findings support further evaluation of this potentially scalable model in larger controlled trials to determine efficacy.
Indexed as
Identifiers
42082799What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.